The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Thierry Chardès Martine Pugniere Isabelle Navarro-Teulon André Pèlegrin |
| Publication date | February 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |